Journal of Dual Diagnosis
Scope & Guideline
Integrating care for a healthier tomorrow.
Introduction
Aims and Scopes
- Co-occurring Disorders Research:
The journal publishes studies on the prevalence, characteristics, and treatment of individuals suffering from both mental health disorders and substance use disorders, highlighting their interconnectedness. - Clinical Interventions and Treatment Strategies:
It focuses on evidence-based practices and innovative treatment approaches aimed at improving outcomes for patients with dual diagnoses, including pharmacological, psychological, and psychosocial interventions. - Impact of Trauma and Stress on Substance Use:
Research exploring the role of trauma, particularly post-traumatic stress disorder (PTSD), in the development and exacerbation of substance use disorders is a core area of focus. - Demographic and Sociocultural Influences:
The journal examines how various demographic factors, such as race, gender, and socioeconomic status, influence the manifestation and treatment of dual diagnosis, aiming to address health disparities. - Public Health Perspectives:
It contributes to the discourse on public health implications of dual diagnosis, including policy impacts and community health strategies, particularly in the context of emerging issues like the COVID-19 pandemic.
Trending and Emerging
- Impact of COVID-19 on Substance Use and Mental Health:
A significant number of recent studies have focused on how the COVID-19 pandemic has affected substance use patterns and mental health outcomes, showcasing the urgent need to adapt treatment and support mechanisms during public health crises. - Use of Technology in Treatment Delivery:
There is an increasing trend towards exploring digital interventions and telehealth solutions for managing dual diagnosis, indicating a shift towards modernizing treatment approaches to improve accessibility and engagement. - Understanding Trauma's Role in Dual Diagnosis:
Emerging research emphasizes the complexities of trauma in relation to substance use and mental health disorders, with a focus on tailored interventions addressing trauma-related symptoms. - Cultural and Racial Considerations in Treatment:
Recent publications have highlighted the importance of understanding cultural and racial factors in the treatment of dual diagnosis, striving for more inclusive and equitable healthcare practices. - Innovative Treatment Modalities:
The exploration of integrative treatment models, such as harm reduction and holistic approaches, is gaining traction, reflecting a broader acceptance of diverse strategies to address the multifaceted nature of dual diagnosis.
Declining or Waning
- Traditional Substance Use Treatment Models:
There appears to be a waning emphasis on conventional treatment models that do not integrate mental health services, as newer studies increasingly advocate for holistic, dual-focused approaches. - Single Disorder Studies:
Research focusing exclusively on either substance use disorders or mental health conditions, without considering their co-occurrence, is becoming less frequent, indicating a shift towards more integrated research frameworks. - Generalized Risk Factors without Contextual Analysis:
There is a decline in studies that discuss risk factors for substance use or mental health disorders in isolation, suggesting a preference for more nuanced analyses that consider the interplay of various factors in dual diagnosis. - Static Epidemiological Studies:
Epidemiological studies that do not address contemporary issues, such as the impact of recent societal changes or the pandemic on dual diagnosis, are less represented, indicating a need for more dynamic and contextually relevant research. - Focus on Non-Evidence-Based Interventions:
Research centered on interventions lacking rigorous evidence or those that do not demonstrate efficacy in dual diagnosis contexts is decreasing, as the journal prioritizes high-quality, evidence-based studies.
Similar Journals
Therapeutic Communities
Championing progress in clinical psychology and psychiatry.Therapeutic Communities, a publication of EMERALD GROUP PUBLISHING LTD, has been a significant contributor to the fields of clinical psychology, psychiatry, and mental health since its inception in 1992. With the ISSN 0964-1866 and E-ISSN 2052-4730, this journal aims to disseminate innovative research and comprehensive reviews that advance our understanding of therapeutic communities and their impact on psychological well-being. Although currently ranked in the Q4 category for Clinical Psychology and Health Professions, the journal continues to strive towards elevating scholarly discourse and practice in mental health settings. Located in the United Kingdom, the journal does not offer open access, but its content remains vital for researchers and practitioners seeking to explore therapeutic modalities and community-based interventions. As the landscape of mental health care evolves, Therapeutic Communities stands as a crucial platform for sharing insights and fostering collaboration among professionals in this essential domain.
Asia-Pacific Psychiatry
Advancing Mental Health Knowledge Across the Asia-PacificAsia-Pacific Psychiatry is a leading academic journal published by WILEY, focused on the diverse and rapidly evolving fields of psychiatry and mental health within the Asia-Pacific region. With an ISSN of 1758-5864 and an E-ISSN of 1758-5872, this journal has been recognized for its significant impact, holding a Q1 ranking in Medicine (miscellaneous) and a Q2 ranking in Psychiatry and Mental Health as of 2023. Its commendable Scopus ranking places it at Rank #83 out of 567 in its category, highlighting its influence and relevance in contemporary research. The journal aims to facilitate the dissemination of high-quality research, reviews, and clinical insights that address mental health challenges, promote global understanding, and encourage collaboration among professionals and academics. Although it is not an open-access journal, the high impact factor underscores its value in the scholarly community, making it an essential resource for researchers, clinicians, and students dedicated to enhancing mental health practices and policies in the region and beyond.
Substance Abuse
Elevating the understanding of complex substance use issues.Substance Abuse is a premier scholarly journal published by SAGE Publications Inc, dedicated to advancing the understanding and treatment of substance use disorders. With an established presence from 1995 to 2023, the journal boasts an impressive Q1 ranking in both Medicine (miscellaneous) and Psychiatry and Mental Health, positioning it among the top tier of academic publications in these fields. Researchers and professionals will find its articles, which are grounded in rigorous empirical studies and innovative interventions, essential for addressing the complex and multifaceted nature of substance abuse. Although not an open access publication, Substance Abuse maintains a commitment to sharing valuable insights and findings, making it a vital resource for those looking to enhance their knowledge and practice. Located in Thousand Oaks, CA, this journal serves as a critical forum for international dialogue and research dissemination, ensuring that current trends and challenges in substance use are thoughtfully examined and discussed within the academic community.
PSYCHOLOGICAL MEDICINE
Shaping the future of psychological and medical understanding.PSYCHOLOGICAL MEDICINE is a leading journal in the field of psychiatry and psychology, published by Cambridge University Press. With its ISSN 0033-2917 and E-ISSN 1469-8978, this journal has firmly established itself as a premier platform for cutting-edge research since its inception in 1970. It consistently ranks in the top quartile for both Applied Psychology and Psychiatry and Mental Health, reflecting its exceptional impact in the field, with a 2023 Scopus ranking of #36 out of 567 in Psychiatry and Mental Health, and #21 out of 249 in Applied Psychology. The journal aims to publish comprehensive studies that explore the interplay between psychological phenomena and medical health, contributing vital insights that advance both theoretical understanding and clinical practice. Although it is not an Open Access journal, PSYCHOLOGICAL MEDICINE remains a vital resource for researchers, professionals, and students committed to the scientific investigation of mental health issues.
DRUG AND ALCOHOL DEPENDENCE
Innovating solutions for addiction and dependency issues.Drug and Alcohol Dependence is a premier journal published by Elsevier Ireland Ltd, dedicated to the rigorous exploration and analysis of substance use disorders, including drug and alcohol dependencies. With its established history since 1975 and a remarkable convergence of research extending to 2024, the journal holds a prestigious position within the academic community, evidenced by its Q1 ranking in multiple categories, including Pharmacology, Psychiatry and Mental Health, and Toxicology for 2023. It ranks impressively among its peers, underscored by Scopus rankings of #46, #99, and #27 in key fields related to medical pharmacology and toxicology. As a non-open access title, it caters to a global readership of researchers, professionals, and students, providing them with peer-reviewed insights into critical developments and innovative methodologies in the field. The journal’s commitment to advancing knowledge and understanding of drug and alcohol dependence is essential for addressing the global challenges posed by substance use, making it a valuable resource for all stakeholders in public health and clinical practice.
Neuropsychopharmacology Reports
Exploring the intersection of pharmacology and psychology.Neuropsychopharmacology Reports is a leading open-access journal published by WILEY, dedicated to advancing the fields of clinical psychology, pharmacology, psychiatry, and mental health. Established in 2018, the journal aims to disseminate high-quality research findings, critical reviews, and innovative methodologies that elucidate the complexities of neuropsychopharmacology in enhancing mental health outcomes. With an impressive impact indicated by its Q2 rankings in several categories including Clinical Psychology and Pharmacology (medical) as of 2023, Neuropsychopharmacology Reports stands out as a vital resource for researchers, professionals, and students keen on exploring the interplay between pharmacological interventions and psychological well-being. The journal’s open-access nature ensures that critical advancements in this rapidly evolving field are readily available to a global audience, fostering collaboration and discourse among scholars and practitioners alike. Building on its indexed status with Scopus, the journal is positioned as a noteworthy contributor to ongoing discussions and developments in psychiatry and medical pharmacology.
Substance Abuse and Rehabilitation
Driving change through peer-reviewed excellence.Substance Abuse and Rehabilitation, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to the study and treatment of substance abuse and related rehabilitation practices. With its ISSN 1179-8467, this journal provides a vital platform for researchers, clinicians, and students to disseminate their findings and insights in a field increasingly relevant to public health. Since becoming open access in 2010, the journal has enhanced its reach, allowing for a broader audience to engage with cutting-edge research and reviews that address the complexities of substance abuse disorders. The journal aims to foster innovation and interdisciplinary collaboration by publishing high-quality peer-reviewed articles that cover a wide range of topics, including addiction therapy, policy implications, and the social determinants of substance use. As a vital resource within the realm of addiction research, Substance Abuse and Rehabilitation plays a crucial role in driving forward knowledge and practices that can improve outcomes for individuals and communities affected by substance use issues.
DRUG AND ALCOHOL REVIEW
Illuminating the path to effective substance use solutions.DRUG AND ALCOHOL REVIEW, published by Wiley, is a leading journal dedicated to advancing the scholarship in the fields of drug and alcohol research. Since its inception in 1989, this esteemed publication has provided a critical platform for the dissemination of innovative research findings, reviews, and theoretical papers, addressing pressing issues in substance use and addiction. With an impact factor that places it in the Q1 category in both Health (social science) and Medicine (miscellaneous), it ranks #78 out of 371 in the Scopus index for Health and #115 out of 398 in Medicine, reflecting its significant influence and high citation rates among scholars. The journal is committed to fostering a multidisciplinary approach, integrating perspectives from psychology, sociology, public health, and medicine, to inform policy and practice. Accessible to researchers and practitioners alike, *DRUG AND ALCOHOL REVIEW* serves as an essential resource for anyone invested in understanding and addressing the complexities of drug and alcohol use in society.
Journal of Mental Health and Human Behaviour
Bridging research and practice for impactful human behaviour change.The Journal of Mental Health and Human Behaviour is a distinguished publication dedicated to advancing the field of mental health, focusing on innovative research and practical applications that enhance human behaviour and overall well-being. Published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, this journal has been an open-access platform since 2014, enabling wider dissemination of knowledge and fostering collaboration among researchers, professionals, and students globally. With an ISSN of 0971-8990 and E-ISSN 2543-1897, it aims to provide a comprehensive array of peer-reviewed articles that cover various facets of mental health, including psychological theories, therapeutic practices, and sociocultural influences. The journal plays an integral role in bridging the gap between research and practice, making it essential for those who are committed to improving mental health outcomes and advocating for human behaviour change. Published in India, the journal not only highlights regional issues but also contributes to international discussions on mental health trends and interventions, affirming its importance in a rapidly evolving field.
BJPsych Advances
Advancing psychiatric knowledge for a healthier tomorrow.BJPsych Advances is a distinguished journal dedicated to the field of Psychiatry and Mental Health, published by Cambridge University Press. With an ISSN of 2056-4678 and an E-ISSN of 2056-4686, this journal serves as a crucial platform for disseminating high-quality research and advancements in psychiatric science. Holding a position in the Q3 quartile as of 2023, it ranks 330 out of 567 in the Scopus database, representing a significant contribution to the mental health community, with a 41st percentile status. The journal not only covers recent innovations and methodologies but also emphasizes practical applications in clinical settings, making it an essential resource for researchers, practitioners, and students alike. With a commitment to fostering a deeper understanding of psychiatric disorders and their implications, BJPsych Advances plays a vital role in enhancing the standards of mental healthcare across the globe, bridging the gap between academic research and clinical practice.